ReviewWorld journal of clinical cases2023

Immune-related adverse events induced by programmed death protein-1 inhibitors from the perspective of lymphoma immunotherapy.

Yong-Zhe Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.